Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-11-21FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Granules Pharmaceuticals Inc., authorizing an additional form…
-
FDA approval · 2023-11-01FDA Approved: VENLAFAXINE — Supplemental Application (Zydus Lifesciences Limited)
FDA granted supplemental approval for venlafaxine from Zydus Lifesciences Limited, signaling an approved modification to an existing generic…
-
FDA approval · 2023-09-22FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline hydrochloride from Granules Pharmaceuticals Inc. The action confirms continued approv…
-
FDA approval · 2023-08-21FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Venlafaxine from BluePoint Laboratories, confirming a generic venlafaxine product (venlafaxine h…
-
FDA approval · 2023-08-21FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, Inc., updating the generic product under ANDA 07…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-18FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline hydrochloride (generic) manufactured by Mylan Pharmaceuticals Inc.
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for venlafaxine hydrochloride, a generic antidepressant.
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
FDA approved a supplemental application for venlafaxine hydrochloride by Vertical Pharmaceuticals, LLC.
-
FDA approval · 2023-08-18FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma's supplemental application to market a generic fluvoxamine maleate product.
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Yaopharma Co., Ltd.)
FDA approved a supplemental application for venlafaxine hydrochloride from Yaopharma Co., Ltd., enabling the generic drug to be marketed. Th…
-
FDA approval · 2023-08-18FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Alvogen, Inc.)
FDA approved a supplemental application for sertraline hydrochloride (Alvogen), resulting in labeling changes to the approved NDA.
-
FDA approval · 2023-08-18FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC. The approval updates the …
-
FDA approval · 2023-08-18FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for paroxetine submitted by Padagis US LLC. This action represents an additional regulatory appr…
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Venlafaxine Hydrochloride from Dr. Reddy's Laboratories Limited for a generic venlafaxine hydroc…
-
FDA approval · 2023-08-18FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Venlafaxine from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. under an ANDA.
-
FDA approval · 2023-08-09FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., indicating an update to the produ…
-
FDA approval · 2023-06-07FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride by Macleods Pharmaceuticals Limited.
-
FDA approval · 2023-05-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved a generic version of venlafaxine hydrochloride from Granules Pharmaceuticals Inc. via an Original Application (ANDA), a generic…
-
FDA approval · 2023-04-12FDA Approved: VENLAFAXINE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original generic application for venlafaxine. The approval covers generic venlafaxine for the treatmen…
-
FDA approval · 2023-03-31FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Granules Pharmaceuticals' sertraline hydrochloride generic product, enabling its marketing in th…
-
FDA approval · 2023-03-30FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA granted supplemental approval for a generic venlafaxine hydrochloride product from Aurobindo Pharma Limited.
-
FDA approval · 2023-03-23FDA Approved: PAROXETINE — Supplemental Application (Modavar Pharmaceuticals LLC)
FDA approved a supplemental application for generic paroxetine filed by Modavar Pharmaceuticals LLC under ANDA212645.
-
FDA approval · 2023-01-31FDA Approved: PAROXETINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for paroxetine from ANI Pharmaceuticals, indicating an approved change to the product (e.g., lab…
-
FDA approval · 2023-01-25FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) filed by Roerig.
-
FDA approval · 2023-01-13FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for alprazolam from Mylan Pharmaceuticals Inc., indicating a revised or expanded approval under an N…